© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending February 18, 2022.
Welcome to NeurologyLive®'s Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive®'s widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
With the physician deficit projected to grow larger within a decade, this global challenge has become a major focus of large organizations and medical societies. The February issue's cover story tackles how this challenge has affected neurology.
In episode 16 of the NeurologyLive® Peer Exchange™, "Unmet Needs in Treating Insomnia," the panel of sleep experts closes their discussion on insomnia by sharing their final thoughts and advice for community physicians.
The Samuel W. Fordyce professor and director of Geriatric Psychiatry at the St Louis University School of Medicine provided insight on critical aspects of telehealth use for assessing and managing psychosis in patients with neurodegenerative diseases.
In the February issue of NeurologyLive®, Adolfo Ramirez-Zamora, MD, writes on how heterogeneity suggests that identifying different types of Parkinson disease could improve patient management, the understanding of underlying disease mechanisms, and the development of target-specific therapies.
In a time when complex medical communication to the public is on display, Daniel Ackerman, MD, FAAN, writes about the need to ensure patient comprehension is of utmost importance for vascular neurologists in the February issue of NeurologyLive®.
Evusheld Increased Attenuated SARS-CoV-2 Antibodies From MS B-Cell Depleting Medications
NeurologyLive® Friday 5 — June 24, 2022
Exploiting Anti-CD3 Antibodies, Relevant Biomarkers in Progressive MS: Tanuja Chitnis, MD
FDA Places Clinical Hold on Duchenne Muscular Dystrophy Drug SRP-5051 Amid Safety Concerns